Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".
Levels of sex steroid and cardiovascular disease measures in premenopausal and hormone-treated women at midlife: implications for the "timing hypothesis".
复制标题
DOI:
10.1001/archinte.168.19.2146
复制
发表时间:
2008-10-27
影响因子:
--
通讯作者:
McConnell, Daniel
中科院分区:
文献类型:
--
作者:
Sowers, MaryFran R.;Randolph, John, Jr.;Jannausch, Mary;Lasley, Bill;Jackson, Elizabeth;McConnell, Daniel
The “timing hypothesis”, in addressing findings from the Women’s Health Initiative trial, suggests that hormone therapy (HT) use should be initiated within six years of the menopause transition to extend a favorable estrogenic environment after menopause. We compared sex steroid and cardiovascular profiles at visit 05 in a community-based, longitudinal study of the menopause transition (Study of Women’s Health Across the Nation). Women, aged 47–57 years, were in one of four groups: premenopausal, using conjugated equine estrogen (CEE) with or without progestin, or postmenopausal (<5 years). Cardiovascular assays included low density lipoprotein cholesterol (LDL-c), oxidized LDL-c, high density lipoprotein cholesterol (HDL-c), triglycerides, apolipoproteins A-1 and B, F2a-isoprostanes, C-reactive protein (CRP), and lipoprotein(a)-1. Sex steroid assays were for estradiol (E2), estrogen receptor ligand load (ERLL), 2-hydroxyestrone (2-OHE1), 16α-hydroxyestrone (16α-OHE1), total testosterone, and sex hormone-binding globulin (SHBG). HT users had 50% higher SHBG levels (p<0.0001 for both groups), which limits sex steroids binding to their receptors, and higher excreted estrone metabolites (more than 60%, p<0.0001 for both groups) than pre- or postmenopausal women. These were, in turn, associated with higher F2a-isoprostanes, an oxidative stress measure, compared to premenopausal women. HT users had a more favorable HDL-c/LDL-c ratio than pre- or postmenopausal women (p<0.01), but higher triglyceride levels (p<0.01). Though HT users had some more favorable lipid profiles than pre- and postmenopausal women, there was evidence of adverse HT effects even in women free of atherosclerosis evaluated within the approximate 6-year time period proposed with the “timing hypothesis”.
登录
查看更多内容
DOI:
10.3109/13697139809080677
发表时间:
1998-03-01
期刊:
Climacteric : the journal of the International Menopause Society
影响因子:
--
作者:
Dudley, E C;Hopper, J L;Dennerstein, L
通讯作者:
Dennerstein, L
影响因子:
39.2
作者:
Grady, D;Wenger, NK;Hulley, S
通讯作者:
Hulley, S
影响因子:
10.4
作者:
Natarajan K;Overstreet JW;Rogers JM;Denison MS;Chen J;Lohstroh PN;McConnell DS;Lasley BL
通讯作者:
Lasley BL
影响因子:
2.7
作者:
KLUG, TL;BRADLOW, HL;SEPKOVIC, DW
通讯作者:
SEPKOVIC, DW
影响因子:
4.8
作者:
Sotiriou, SN;Orlova, VV;Chavakis, T
通讯作者:
Chavakis, T